A new class of weight loss drugs is transforming the U.S. healthcare system in ways that could extend to equally hard-to-treat areas.
Categories: Addiction controlBusinessCardiovascular diseaseCHICAGOConsumer habitsConsumer purchasesDrugstore chainEli LillyEnormous demandFDAGLP-1sHard-to-treat areasHealth insurersHealthcare systemJohn DriscollLawrence TabakLower overall healthcare costsMounjaroNIHNovo NordiskObesityreimbursementSatiety regionsavingsSemaglutidesubstance abuseTirzepatideTodays HeadlinesTotal Health conferenceTransformingType 2 diabetesU.S. healthcareU.S. list pricesUnited StatesWalgreensWegovyWeight loss drugsZepbound